These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 33296409)

  • 21. Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting.
    Uddin MKM; Shirin T; Hossain ME; Alam AN; Ami JQ; Hasan R; Miah M; Shaly NJ; Ahmed S; Rahman SMM; Rahman M; Banu S
    Microbiol Spectr; 2021 Dec; 9(3):e0046821. PubMed ID: 34730436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand.
    Chaimayo C; Kaewnaphan B; Tanlieng N; Athipanyasilp N; Sirijatuphat R; Chayakulkeeree M; Angkasekwinai N; Sutthent R; Puangpunngam N; Tharmviboonsri T; Pongraweewan O; Chuthapisith S; Sirivatanauksorn Y; Kantakamalakul W; Horthongkham N
    Virol J; 2020 Nov; 17(1):177. PubMed ID: 33187528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical symptoms, SARS-CoV-2 test results and immunisation rates in 456 residents from eight nursing homes facing a COVID-19 outbreak.
    Blain H; Gamon L; Tuaillon E; Pisoni A; Giacosa N; Albrand M; Miot S; Rolland Y; Picot MC; Bousquet J
    Age Ageing; 2021 May; 50(3):641-648. PubMed ID: 33620381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology and clinical features of emergency department patients with suspected COVID-19: Insights from Australia's 'second wave' (COVED-4).
    O'Reilly GM; Mitchell RD; Mitra B; Akhlaghi H; Tran V; Furyk JS; Buntine P; Wong A; Gangathimmaiah V; Knott J; Raos M; Chatterton E; Sevior C; Parker S; Baker S; Loughman A; Lowry N; Freeman D; Sri-Ganeshan M; Chapman N; Siu S; Noonan MP; Smit V; Cameron PA;
    Emerg Med Australas; 2021 Apr; 33(2):331-342. PubMed ID: 33315310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
    Dixon BE; Wools-Kaloustian KK; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
    PLoS One; 2021; 16(3):e0241875. PubMed ID: 33760821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 assessment in family practice-A clinical decision rule based on self-rated symptoms and contact history.
    Schneider A; Rauscher K; Kellerer C; Linde K; Kneissl F; Hapfelmeier A
    NPJ Prim Care Respir Med; 2021 Nov; 31(1):46. PubMed ID: 34824286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modelling of a triage scoring tool for SARS-COV-2 PCR testing in health-care workers: data from the first German COVID-19 Testing Unit in Munich.
    Hohl HT; Froeschl G; Hoelscher M; Heumann C
    BMC Infect Dis; 2022 Aug; 22(1):664. PubMed ID: 35915394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
    Khan M; Khan H; Khan S; Nawaz M
    J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
    [No Abstract]   [Full Text] [Related]  

  • 31. The experience of the health care workers of a severely hit SARS-CoV-2 referral Hospital in Italy: incidence, clinical course and modifiable risk factors for COVID-19 infection.
    Colaneri M; Novelli V; Cutti S; Muzzi A; Resani G; Monti MC; Rona C; Grugnetti AM; Rettani M; Rovida F; Zuccaro V; Triarico A; Marena C
    J Public Health (Oxf); 2021 Apr; 43(1):26-34. PubMed ID: 33140084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of Nucleic Acid and Antibody Detection Results for SARS-CoV-2 Infection.
    Chen J; Niu Z; Li H; Tang D; Zhang P
    Arch Iran Med; 2021 May; 24(5):427-433. PubMed ID: 34196209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe acute respiratory syndrome coronavirus (SARS-CoV-2) is not detected in the vagina: A prospective study.
    Takmaz O; Kaya E; Erdi B; Unsal G; Sharifli P; Agaoglu NB; Ozbasli E; Gencer S; Gungor M
    PLoS One; 2021; 16(9):e0253072. PubMed ID: 34591849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Over 90% of clinical swabs used for SARS-CoV-2 diagnostics contain sufficient nucleic acid concentrations.
    Klingen RL; Katschinski B; Anastasiou OE; Ross RS; Dittmer U; Le-Trilling VTK; Trilling M
    J Med Virol; 2021 May; 93(5):2848-2856. PubMed ID: 33289117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.
    Lahner E; Dilaghi E; Prestigiacomo C; Alessio G; Marcellini L; Simmaco M; Santino I; Orsi GB; Anibaldi P; Marcolongo A; Annibale B; Napoli C
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32575505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-COV-2 infections in children: The role of fibrinogen in predicting diagnosis and severity: A retrospective cohort study.
    Akkoc G; Ağbaş A; Göksu E; Beyaz S; Yıldız F; Bayramoğlu E; Yolcu C; Ayça S; Dolu NÇ; Şahin K; Koldaş M; Elevli M
    Adv Clin Exp Med; 2024 Jan; 33(1):31-38. PubMed ID: 37191449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.